Clinicopathologic characterization of diffuse-large-B-cell lymphoma with an associated serum monoclonal IgM component. - Wikidata - wikimedia - TriplyDB

Clinicopathologic characterization of diffuse-large-B-cell lymphoma with an associated serum monoclonal IgM component.

Clinicopathologic characterization of diffuse-large-B-cell lymphoma with an associated serum monoclonal IgM component.

http://www.wikidata.org/entity/Q37685724

about

Constitutive NF- κ B Activation Underlines Major Mechanism of Drug Resistance in Relapsed Refractory Diffuse Large B Cell Lymphoma Clinicopathologic significance of MYD88 L265P mutation in diffuse large B-cell lymphoma: a meta-analysis.Subtype-specific addiction of the activated B-cell subset of diffuse large B-cell lymphoma to FOXP1.Activating somatic mutations in diffuse large B-cell lymphomas: lessons from next generation sequencing and key elements in the precision medicine era.Synchronous diffuse large B-cell lymphoma and malignant clonal plasma cells in bone marrow as primary presentation: a diagnostic and therapeutic challenge.Extranodal diffuse large B-cell lymphoma with monoclonal gammopathy: an aggressive and primary refractory disease responding to an immunomodulatory agent.The significance of serum immunoglobulin paraprotein in diffuse large B-cell lymphoma.Durable response after VNCOP-B and rituximab in an elderly patient with high-grade B-cell lymphoma.

P2860

Q26853170-DC8F7FD3-C6CF-48BD-AC2B-9EBE383CA2A4 Q33687549-BA8D379D-1AB7-4DAA-9168-9F00C163C8AB Q36563205-C487DA75-C89F-409B-9AED-E411C8A50D8B Q38240579-32F7F2F6-283E-4619-878F-7C781574A1D6 Q40831170-06623579-E472-4E1F-BD8D-719DB7787A86 Q43104067-542897B0-8571-400E-9E97-A20FCA9611CD Q48195072-F3BA8B78-A571-4A24-9D7C-BA43B18A6776 Q48578904-B8583526-96A8-4C22-A03E-3B6017928BE4

P2860

Clinicopathologic characterization of diffuse-large-B-cell lymphoma with an associated serum monoclonal IgM component.

http://www.wikidata.org/entity/Q37685724

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 04 April 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Clinicopathologic characteriza ...... erum monoclonal IgM component.

@en

Clinicopathologic characteriza ...... erum monoclonal IgM component.

@nl

type

label

Clinicopathologic characteriza ...... erum monoclonal IgM component.

@en

Clinicopathologic characteriza ...... erum monoclonal IgM component.

@nl

prefLabel

Clinicopathologic characteriza ...... erum monoclonal IgM component.

@en

Clinicopathologic characteriza ...... erum monoclonal IgM component.

@nl

P1433

Q37685724-81AAEA4D-9FAE-4F75-B482-090C1DB26724

P1476

Q37685724-0D6567F4-E96E-40A7-8265-D0E658571746

P2093

Q37685724-1F7D533C-6FA9-4C8B-B3F4-5D6C53D1D295

Q37685724-4E526905-418A-4C8F-9338-E9BACF26FD16

Q37685724-633B9C1A-F479-4065-9437-5D89C8653356

Q37685724-66F647D2-2FEF-4CAB-8922-03C48DB5013A

Q37685724-69FF99A2-0750-42FD-9091-FA9DCDD4A9DE

Q37685724-799871B8-4840-42E5-A2A5-50B707450928

Q37685724-7B414D99-7493-484F-ABBA-69007AB228DC

Q37685724-ECEBFDC9-0B97-40D6-9718-48D763B4E808

P2860

Q37685724-01F8FBBE-C0B0-4EAA-B086-7B65EF9718E5

Q37685724-02766C7E-A247-4C41-A9EB-DE8A0D690591

Q37685724-07F75424-6E13-41E6-B728-373BB624FCF2

Q37685724-08A94B88-490E-43DC-954B-A5B13E8C2ADB

Q37685724-0FA7220F-AC61-42D8-B474-3D09B1E29866

Q37685724-1C6A8527-4407-489A-8252-3CE14833C4F5

Q37685724-2DC3965B-20D9-463F-AD4F-746F560EDEFF

Q37685724-386C4373-596C-4338-8DD2-07670E418998

Q37685724-460C705F-1855-4ECB-B380-E3C7FEB64D75

Q37685724-4C27FD06-8D51-4246-9BED-5753698C3AC4

P304

Q37685724-5FBA90E0-F9E1-436B-A34F-B5389D79DA9F

P31

Q37685724-436000FD-3D8D-4436-A3C3-B4212D14C62C

P356

Q37685724-4DDDB4D6-EF05-452E-AF29-F9F9701326C4

P407

Q37685724-E90AC3DC-AEAD-4C9A-9E47-F367838A0722

P433

Q37685724-3456F316-46C5-4F03-95BC-0243393401E1

P478

Q37685724-38B1F0C5-F268-4E2F-BEB3-1CAADE900204

P50

Q37685724-C0E74E55-9398-4CD1-899E-DB80CD3001A4

Q37685724-DDA6F96E-3BF6-4F92-8031-433E8103A890

P577

Q37685724-0BB610E5-8C58-4916-BE7A-D1086192A54B

P5875

Q37685724-DAD4D623-57DB-42ED-8CA0-0D8E083E7358

P698

Q37685724-75CE066D-CC8B-4D6A-9D72-9B2452B64373

P932

Q37685724-0B3094B7-B393-450F-8177-B6A392BAB90B

P356

JOURNAL.PONE.0093903

P1433

P1476

Clinicopathologic characteriza ...... erum monoclonal IgM component.

@en

P2093

Arianna Di Napoli

http://www.w3.org/2001/XMLSchema#string

Bruno Monarca

http://www.w3.org/2001/XMLSchema#string

Caterina Talerico

http://www.w3.org/2001/XMLSchema#string

Caterina Tatarelli

http://www.w3.org/2001/XMLSchema#string

Gerardo Salerno

http://www.w3.org/2001/XMLSchema#string

Luigi Ruco

http://www.w3.org/2001/XMLSchema#string

Mariangela Lombardi

http://www.w3.org/2001/XMLSchema#string

Stefania Scarpino

http://www.w3.org/2001/XMLSchema#string

P2860

Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing

A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

Prognostic significance of MYC, BCL2, and BCL6 rearrangements in patients with diffuse large B-cell lymphoma treated with cyclophosphamide, doxorubicin, vincristine, and prednisone plus rituximab

Oncogenically active MYD88 mutations in human lymphoma

Bortezomib as salvage treatment for heavily pretreated relapsed lymphoma patients: a multicenter retrospective study.

Aggressive large B-cell lymphoma with plasma cell differentiation: immunohistochemical characterization of plasmablastic lymphoma and diffuse large B-cell lymphoma with partial plasmablastic phenotype

Elevated serum free light chains are associated with event-free and overall survival in two independent cohorts of patients with diffuse large B-cell lymphoma.

P304

e93903

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0093903

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

M Christina Cox

P577

2014-04-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

261408437

http://www.w3.org/2001/XMLSchema#string

P698

24705344

http://www.w3.org/2001/XMLSchema#string

P932

3976325

http://www.w3.org/2001/XMLSchema#string